The interhemispheric connections of the striatum: Implications for Parkinson's disease and drug-induced dyskinesias

Brain Research Bulletin

Volumn 87, Issue 1, 2012, Pages 1-9

  Lieu, Christopher A ^a   Subramanian, Thyagarajan ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Basal ganglia; Dopamine replacement therapy; Movement disorders; Nigrostriatal degeneration

Indexed keywords

DOPAMINE; LEVODOPA;

BASAL GANGLION; CELL LOSS; CORPUS STRIATUM; DRUG EXPOSURE; DYSKINESIA; ELECTROPHYSIOLOGY; HEMISPHERE; HUMAN; MOTOR DYSFUNCTION; NERVE PROJECTION; NEUROANATOMY; NEUROCHEMISTRY; NEUROMODULATION; NEUROPHYSIOLOGY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; RHESUS MONKEY; SYMPTOM;

ADRENERGIC AGENTS; ANIMALS; BEHAVIOR, ANIMAL; CORPUS STRIATUM; DOPAMINE; DYSKINESIA, DRUG-INDUCED; NEURAL PATHWAYS; OXIDOPAMINE; PARKINSON DISEASE; SUBSTANTIA NIGRA;

EID: 84155162662     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2011.09.013     Document Type: Review

References (73)

1. Alloway K.D., Lou L., Nwabueze-Ogbo F., Chakrabarti S. Topography of cortical projections to the dorsolateral neostriatum in rats: multiple overlapping sensorimotor pathways. J. Comp. Neurol. 2006, 499:33-48.
2. Alloway K.D., Smith J.B., Beauchemin K.J., Olson M.L. Bilateral projections from rat MI whisker cortex to the neostriatum, thalamus, and claustrum: forebrain circuits for modulating whisking behavior. J. Comp. Neurol. 2009, 515:548-564.
3. Altar A., Neve K.A., Loughlin S.E., Marshall J.F., Fallon J.H. The crossed mesostriatal projection: neurochemistry and developmental response to lesion. Brain Res. 1983, 279:1-8.
4. Benazzouz A., Gross C., Dupont J., Bioulac B. MPTP induced hemiparkinsonism in monkeys: behavioral, mechanographic, electromyographic and immunohistochemical studies. Exp. Brain Res. 1992, 90:116-120.
5. Benazzouz A., Boraud T., Feger J., Burbaud P., Bioulac B., Gross C. Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates: a comparison with L-Dopa treatment. Mov. Disord. 1996, 11:627-632.
6. Bezard E., Ferry S., Mach U., Stark H., Leriche L., Boraud T., Gross C., Sokoloff P. Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function. Nat. Med. 2003, 9:762-767.
7. Bibbiani F., Costantini L.C., Patel R., Chase T.N. Continuous dopaminergic stimulation reduces risk of motor complications in parkinsonian primates. Exp. Neurol. 2005, 192:73-78.
8. Castellano M.A., Rodriguez Diaz M. Nigrostriatal dopaminergic cell activity is under control by substantia nigra of the contralateral brain side: electrophysiological evidence. Brain Res. Bull. 1991, 27:213-218.
9. Castellano M.A., Rivero F.L., Rodriguez M. Spontaneous firing of nigrostriatal dopaminergic neurons in split-brain rats. Neurosci. Lett. 1993, 162:1-4.
10. Cheng H.W., Tong J., McNeill T.H. Lesion-induced axon sprouting in the deafferented striatum of adult rat. Neurosci. Lett. 1998, 242:69-72.
11. Collier T.J., Dung Ling Z., Carvey P.M., Fletcher-Turner A., Yurek D.M., Sladek J.R., Kordower J.H. Striatal trophic factor activity in aging monkeys with unilateral MPTP-induced parkinsonism. Exp. Neurol. 2005, 191(Suppl. 1):S60-S67.
12. Collier T.J., Lipton J., Daley B.F., Palfi S., Chu Y., Sortwell C., Bakay R.A., Sladek J.R., Kordower J.H. Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonism. Neurobiol. Dis. 2007, 26:56-65.
13. Collingridge G.L. Electrophysiological evidence for the existence of crossed nigrostriatal fibers. Experientia 1982, 38:812-813.
14. Consolazione A., Bentivoglio M., Goldstein M., Toffano G. Evidence for crossed catecholaminergic nigrostriatal projections by combining wheat germ agglutinin-horseradish peroxidase retrograde transport and tyrosine hydroxylase immunocytochemistry. Brain Res. 1985, 338:140-143.
15. Cospito J.A., Kultas-Ilinsky K. Synaptic organization of motor corticostriatal projections in the rat. Exp. Neurol. 1981, 72:257-266.
16. Deogaonkar M., Subramanian T. Pathophysiological basis of drug-induced dyskinesias in Parkinson's disease. Brain Res. Brain Res. Rev. 2005, 50:156-168.
17. Douglas R., Kellaway L., Mintz M., van Wageningen G. The crossed nigrostriatal projection decussates in the ventral tegmental decussation. Brain Res. 1987, 418:111-121.
18. Emborg M.E. Nonhuman primate models of Parkinson's disease. ILAR J. 2007, 48:339-355.
19. Emborg M.E., Moirano J., Schafernak K.T., Moirano M., Evans M., Konecny T., Roitberg B., Ambarish P., Mangubat E., Ma Y., Eidelberg D., Holden J., Kordower J.H., Leestma J.E. Basal ganglia lesions after MPTP administration in rhesus monkeys. Neurobiol. Dis. 2006, 23:281-289.
20. Fahn S. A new look at levodopa based on the ELLDOPA study. J. Neural Trans. Suppl. 2006, 419-426.
21. Fallon J.H., Ziegler B.T. The crossed cortico-caudate projection in the rhesus monkey. Neurosci. Lett. 1979, 15:29-32.
22. Fallon J.H., Wang C., Kim Y., Canepa N., Loughlin S., Seroogy K. Dopamine- and cholecystokinin-containing neurons of the crossed mesostriatal projection. Neurosci. Lett. 1983, 40:233-238.
23. Faraji J., Metz G.A. Sequential bilateral striatal lesions have additive effects on single skilled limb use in rats. Behav. Brain Res. 2007, 177:195-204.
24. Fass B., Butcher L.L. Evidence for a crossed nigrostriatal pathway in rats. Neurosci. Lett. 1981, 22:109-113.
25. Fisher R.S., Shiota C., Levine M.S., Hull C.D., Buchwald N.A. Subcortical crossed axonal projections to the caudate nucleus of the cat: a double-labelling study. Neurosci. Lett. 1984, 51:25-30.
26. Fisher R.S., Boylan M.K., Hull C.D., Buchwald N.A., Levine M.S. Branched projections of cat sensorimotor cortex: multiple retrograde labeling via commissural corticocortical, decussated corticostriatal and undecussated corticostriatal axons. Brain Res. 1986, 384:395-400.
27. Francois C., Percheron G., Yelnik J. Localization of nigrostriatal, nigrothalamic and nigrotectal neurons in ventricular coordinates in macaques. Neuroscience 1984, 13:61-76.
28. Gilmour T.P., Lieu C.A., Nolt M.J., Piallat B., Deogaonkar M., Subramanian T. The effects of chronic levodopa treatments on the neuronal firing properties of the subthalamic nucleus and substantia nigra reticulata in hemiparkinsonian rhesus monkeys. Exp. Neurol. 2011, 228:53-58.
29. Jaeger C.B., Joh T.H., Reis D.J. The effect of forebrain lesions in the neonatal rat: survival of midbrain dopaminergic neurons and the crossed nigrostriatal projection. J. Comp. Neurol. 1983, 218:74-90.
30. Kordower J.H., Emborg M.E., Bloch J., Ma S.Y., Chu Y., Leventhal L., McBride J., Chen E.Y., Palfi S., Roitberg B.Z., Brown W.D., Holden J.E., Pyzalski R., Taylor M.D., Carvey P., Ling Z., Trono D., Hantraye P., Deglon N., Aebischer P. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 2000, 290:767-773.
31. Kordower J.H., Herzog C.D., Dass B., Bakay R.A., Stansell J., Gasmi M., Bartus R.T. Delivery of neurturin by AAV2 (CERE-120)-mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTP-treated monkeys. Ann. Neurol. 2006, 60:706-715.
32. Langston J.W., Quik M., Petzinger G., Jakowec M., Di Monte D.A. Investigating levodopa-induced dyskinesias in the parkinsonian primate. Ann. Neurol. 2000, 47:S79-S89.
33. Lawler C.P., Gilmore J.H., Watts V.J., Walker Q.D., Southerland S.B., Cook L.L., Mathis C.A., Mailman R.B. Interhemispheric modulation of dopamine receptor interactions in unilateral 6-OHDA rodent model. Synapse 1995, 21:299-311.
34. Liang L., DeLong M.R., Papa S.M. Inversion of dopamine responses in striatal medium spiny neurons and involuntary movements. J. Neurosci. 2008, 28:7537-7547.
35. Lieu C.A., Kunselman A.R., Manyam B.V., Venkiteswaran K., Subramanian T. A water extract of Mucuna pruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesias. Parkinsonism Relat. Disord. 2010, 16:458-465.
36. Lieu C.A., Deogaonkar M., Bakay R.A., Subramanian T. Dyskinesias do not develop after chronic intermittent levodopa therapy in clinically hemiparkinsonian rhesus monkeys. Parkinsonism Relat. Disord. 2011, 17:34-39.
37. Loughlin S.E., Fallon J.H. Mesostriatal projections from ventral tegmentum and dorsal raphe: cells project ipsilaterally or contralaterally but not bilaterally. Neurosci. Lett. 1982, 32:11-16.
38. Meredith G.E., Farrell T., Kellaghan P., Tan Y., Zahm D.S., Totterdell S. Immunocytochemical characterization of catecholaminergic neurons in the rat striatum following dopamine-depleting lesions. Eur. J. Neurosci. 1999, 11:3585-3596.
39. Miletich R.S., Bankiewicz K.S., Quarantelli M., Plunkett R.J., Frank J., Kopin I.J., Di Chiro G. MRI detects acute degeneration of the nigrostriatal dopamine system after MPTP exposure in hemiparkinsonian monkeys. Ann. Neurol. 1994, 35:689-697.
40. Mintz M., Douglas R., Kellaway L., van Wageningen G. Hemispheric disconnection and rotational behaviour. Behav. Brain Res. 1985, 17:257-263.
41. Morgan S., Huston J.P. The interhemispheric projection from the substantia nigra to the caudate-putamen as depicted by the anterograde transport of [3H]leucine. Behav. Brain Res. 1990, 38:155-162.
42. Morgan S., Rosenkranz C., Steiner H., Huston J.P. Lack of relationship between the direction of operant turning and horseradish peroxidase uptake by crossed nigro-striatal projections. Brain Res. Bull. 1985, 15:515-518.
43. Morgan S., Steiner H., Rosenkranz C., Huston J.P. Dissociation of crossed and uncrossed nigrostriatal projections with respect to site of origin in the rat. Neuroscience 1986, 17:609-614.
44. Mouradian M.M., Heuser I.J., Baronti F., Fabbrini G., Juncos J.L., Chase T.N. Pathogenesis of dyskinesias in Parkinson's disease. Ann. Neurol. 1989, 25:523-526.
45. Nieoullon A., Cheramy A., Glowinski J. Interdependence of the nigrostriatal dopaminergic systems on the two sides of the brain in the cat. Science 1977, 198:416-418.
46. Nieoullon A., Cheramy A., Leviel V., Glowinski J. Effects of the unilateral nigral application of dopaminergic drugs on the in vivo release of dopamine in the two caudate nuclei of the cat. Eur. J. Pharmacol. 1979, 53:289-296.
47. Papa S.M., Desimone R., Fiorani M., Oldfield E.H. Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesias. Ann. Neurol. 1999, 46:732-738.
48. Pearce R.K., Jackson M., Smith L., Jenner P., Marsden C.D. Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix jacchus). Mov. Disord. 1995, 10:731-740.
49. Pelled G., Bergman H., Goelman G. Bilateral overactivation of the sensorimotor cortex in the unilateral rodent model of Parkinson's disease - a functional magnetic resonance imaging study. Eur. J. Neurosci. 2002, 15:389-394.
50. Pritzel M., Huston J.P., Sarter M. Behavioral and neuronal reorganization after unilateral substantia nigra lesions: evidence for increased interhemispheric nigrostriatal projections. Neuroscience 1983, 9:879-888.
51. Pritzel M., Sarter M., Morgan S., Huston J.P. Interhemispheric nigrostriatal projections in the rat: bifurcating nigral projections and loci of crossing in the diencephalon. Brain Res. Bull. 1983, 10:385-390.
52. Quik M., Cox H., Parameswaran N., O'Leary K., Langston J.W., Di Monte D. Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys. Ann. Neurol. 2007, 62:588-596.
53. Roedter A., Winkler C., Samii M., Walter G.F., Brandis A., Nikkhah G. Comparison of unilateral and bilateral intrastriatal 6-hydroxydopamine-induced axon terminal lesions: evidence for interhemispheric functional coupling of the two nigrostriatal pathways. J. Comp. Neurol. 2001, 432:217-229.
54. Rohlfs A., Nikkhah G., Rosenthal C., Rundfeldt C., Brandis A., Samii M., Loscher W. Hemispheric asymmetries in spontaneous firing characteristics of substantia nigra pars reticulata neurons following a unilateral 6-hydroxydopamine lesion of the rat nigrostriatal pathway. Brain Res. 1997, 761:352-356.
55. Rosell A., Gimenez-Amaya J.M. Double retrograde tracer study of the corticostriatal projections to the cat caudate nucleus. Synapse 2001, 40:35-46.
56. Royce G.J. Cells of origin of subcortical afferents to the caudate nucleus: a horseradish peroxidase study in the cat. Brain Res. 1978, 153:465-475.
57. Salin P., Nieoullon A. The contralateral cortex contributes to the effects of hemidecortication on neuropeptide Y immunoreactivity in the rat striatum. Neurosci. Lett. 1996, 220:179-182.
58. Sauer H., Oertel W.H. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 1994, 59:401-415.
59. Schneider J.S., McLaughlin W.W., Roeltgen D.P. Motor and nonmotor behavioral deficits in monkeys made hemiparkinsonian by intracarotid MPTP infusion. Neurology 1992, 42:1565-1572.
60. Soderstrom K.E., Meredith G., Freeman T.B., McGuire S.O., Collier T.J., Sortwell C.E., Wu Q., Steece-Collier K. The synaptic impact of the host immune response in a parkinsonian allograft rat model: influence on graft-derived aberrant behaviors. Neurobiol. Dis. 2008, 32:229-242.
61. Soderstrom K.E., O'Malley J.A., Levine N.D., Sortwell C.E., Collier T.J., Steece-Collier K. Impact of dendritic spine preservation in medium spiny neurons on dopamine graft efficacy and the expression of dyskinesias in parkinsonian rats. Eur. J. Neurosci. 2010, 31:478-490.
62. Starr P.A., Wichmann T., van Horne C., Bakay R.A. Intranigral transplantation of fetal substantia nigra allograft in the hemiparkinsonian rhesus monkey. Cell. Transplant. 1999, 8:37-45.
63. Steiner H., Morgan S., Huston J.P. Effect of forebrain commissurotomy on recovery from unilateral 6-OHDA lesions of the substantia nigra and circling induced by apomorphine. Behav. Brain Res. 1985, 17:245-249.
64. Steiner H., Weiler H.T., Morgan S., Huston J.P. Asymmetries in crossed and uncrossed nigrostriatal projections dependent on duration of unilateral removal of vibrissae in rats. Exp. Brain Res. 1989, 77:421-424.
65. Steiner H., Weiler H.T., Morgan S., Huston J.P. Time-dependent neuroplasticity in mesostriatal projections after unilateral removal of vibrissae in the adult rat: compartment-specific effects on horseradish peroxidase transport and cell size. Neuroscience 1992, 47:793-806.
66. Subramanian T., Emerich D.F., Bakay R.A., Hoffman J.M., Goodman M.M., Shoup T.M., Miller G.W., Levey A.I., Hubert G.W., Batchelor S., Winn S.R., Saydoff J.A., Watts R.L. Polymer-encapsulated PC-12 cells demonstrate high-affinity uptake of dopamine in vitro and 18F-Dopa uptake and metabolism after intracerebral implantation in nonhuman primates. Cell Transplant. 1997, 6:469-477.
67. Subramanian T., Deogaonkar M., Brummer M., Bakay R. MRI guidance improves accuracy of stereotaxic targeting for cell transplantation in parkinsonian monkeys. Exp. Neurol. 2005, 193:172-180.
68. Subramanian T., Lieu C.A., Guttalu K., Berg D. Detection of MPTP-induced substantia nigra hyperechogenicity in Rhesus monkeys by transcranial ultrasound. Ultrasound Med. Biol. 2010, 36:604-609.
69. Sullivan R.M., Parker B.A., Szechtman H. Role of the corpus callosum in expression of behavioral asymmetries induced by a unilateral dopamine lesion of the substantia nigra in the rat. Brain Res. 1993, 609:347-350.
70. Ungerstedt U., Arbuthnott G.W. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 1970, 24:485-493.
71. Veening J.G., Cornelissen F.M., Lieven P.A. The topical organization of the afferents to the caudatoputamen of the rat. A horseradish peroxidase study. Neuroscience 1980, 5:1253-1268.
72. Winkler C., Kirik D., Bjorklund A., Cenci M.A. L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function. Neurobiol. Dis. 2002, 10:165-186.
73. Xu Q., Jiang X., Ke Y., Zhang S., Xu R., Zeng Y. Gene therapy in hemiparkinsonian rhesus monkeys: long-term survival and behavioral recovery by transplantation of autologous human tyrosine hydroxylase-expressing neural stem cells. Cytotherapy 2010, 12:226-237.